Anti-CD63 (Late Endosomes Marker) Monoclonal Antibody(Clone: NKI/C3)-CF488, Clone: [NKI/C3], Mouse

Catalog Number: ABI-36-3633
Article Name: Anti-CD63 (Late Endosomes Marker) Monoclonal Antibody(Clone: NKI/C3)-CF488, Clone: [NKI/C3], Mouse
Biozol Catalog Number: ABI-36-3633
Supplier Catalog Number: 36-3633
Alternative Catalog Number: ABI-36-3633-0.5AT100MLATUG/ML
Manufacturer: Abeomics
Host: Mouse
Category: Antikörper
Application: FACS, IF
Species Reactivity: Human, Mouse
Immunogen: Smooth plasma membrane fraction of MeWo cells
Conjugation: CF488
Alternative Names: gp55, granulophysin, Lysosomal-associated membrane protein 3 (LAMP-3), Mast cell antigen AD1, melanoma 1 antigen, Melanoma-associated antigen MLA1, Melanoma-associated antigen ME491, MLA1, NGA, Ocular melanoma-associated antigen, OMA81H, PTLGP40, Tetraspanin-30, TSPAN30
This MAb recognizes protein of 26kDa-60kDa, which is identified as CD63. Its epitope is different from that of MAb LAMP3/529. The tetraspanins are integral membrane proteins expressed on cell surface and granular membranes of hematopoietic cells and are components of multi-molecular complexes with specific integrins. The tetraspanin CD63 is a lysosomal membrane glycoprotein that translocates to the plasma membrane after platelet activation. CD63 is expressed on activated platelets, monocytes and macrophages, and is weakly expressed on granulocytes, T cell and B cells. It is located on the basophilic granule membranes and on the plasma membranes of lymphocytes and granulocytes. CD63 is a member of the TM4 superfamily of leukocyte glycoproteins that includes CD9, CD37 and CD53, which contain four transmembrane regions. CD63 may play a role in phagocytic and intracellular lysosome-phagosome fusion events. CD63 deficiency is associated with Hermansky-Pudlak syndrome and is strongly expressed during the early stages of melanoma progression.
Clonality: Monoclonal
Clone Designation: [NKI/C3]
NCBI: 967
UniProt: P08962
Application Dilute: Flow Cytometry (5ul per test per one million cells or 5ul per 100ul of whole blood),Immunofluorescence (1:50-1:100),